Acorda Therapeutics
ACOR
#10566
Rank
A$1.18 M
Marketcap
A$0.95
Share price
0.00%
Change (1 day)
-96.14%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -A$0.41 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are A$0.11 Billion. In 2023 the company made an earning of -A$0.39 Billion a decrease over its 2022 earnings that were of -A$7.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.41 Billion5.34%
2023 -A$0.39 Billion4848.63%
2022 -A$7.69 Million-93.25%
2021 -A$0.12 Billion2.52%
2020 -A$0.12 Billion-69.45%
2019 -A$0.37 Billion-700.62%
2018 A$60.46 M-118.02%
2017 -A$0.34 Billion805.99%
2016 -A$37.05 Million-173.88%
2015 A$50.13 M-6.58%
2014 A$53.66 M20.19%
2013 A$44.65 M18.7%
2012 A$37.61 M-26.54%
2011 A$51.2 M
2009 -A$0.12 Billion10.65%
2008 -A$0.11 Billion86.17%
2007 -A$56.77 Million68.1%
2006 -A$33.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-A$0.37 Billion-7.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$37.61 M-109.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-A$0.12 Billion-71.86%๐Ÿ‡ฉ๐Ÿ‡ช Germany
BioMarin Pharmaceutical
BMRN
A$0.97 B-349.94%๐Ÿ‡บ๐Ÿ‡ธ USA